| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Bioxytran, Inc (BIXT) has 4 insiders with recent SEC Form 4 filings, including 2 buys and 0 sells. BIXT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 379.2K | $15.9K | - | |
| Dir | 372.6K | $15.6K | - | |
| Dir | 210.0K | $8.8K | - | |
| Dir | 203.7K | $8.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 18, 2025 | Hoberman Alan M | Director | Buy | 210,000 | $0.60 | $126,000.00 | New | |
| Aug 15, 2024 | Platt David | CEO | Buy | 1,592,921 | $0.12 | $197,522.20 | +7.9% |